FDA Approves Canakinumab for Gout Flares The US FDA has approved canakinumab (Ilaris) for the treatment of gout flares
Tweet Content
FDA Approves Canakinumab for Gout Flares
The US FDA has approved canakinumab (Ilaris) for the treatment of gout flares in adults who cannot be treated with NSAIDs, colchicine, or repeated courses of corticosteroids.
https://t.co/0IV1V31LJm https://t.co/oua0F9b7Jb
Show on Archive Page
On
Display in Search Results
On
PDQ
Off